Katina Dorton

Ms. Katina Dorton is an Independent Director at Keenova Therapeutics PLC, an Independent Director at TScan Therapeutics, Inc., an Independent Director at Fulcrum Therapeutics, Inc., a Director-Research Triangle Chapter at National Association of Corporate Directors (Virginia) and a Partner at CoRise Co. Llc.
She is on the Board of Directors at Prelude Therapeutics, Inc., Keenova Therapeutics PLC, Sonoma Biotherapeutics, Inc., TScan Therapeutics, Inc., Fulcrum Therapeutics, Inc. and Easter Seals UCP North Carolina & Virginia, Inc. Ms. Dorton was previously employed as an Independent Director by Pandion Therapeutics, Inc., a Chief Financial Officer by NodThera Ltd., a Chief Financial Officer & Executive Vice President by Repare Therapeutics, Inc., a Chief Financial & Accounting Officer by Tectonic Therapeutic, Inc., a Chief Financial Officer by Immatics Biotechnologies GmbH, an Independent Director by US Ecology, Inc. /Old/, an Independent Director by US Ecology, Inc., a Principal Owner by Doric Co. LLC, a Managing Director-Investment Banking by Morgan Stanley, a Managing Director by Needham & Co. LLC, and an Attorney by Sullivan & Cromwell LLP.
She also served on the board at RTP Capital Associates, Inc. She received her undergraduate degree from Duke University, a graduate degree from the University of Virginia and an MBA from George Washington University.